|
gptkbp:instanceOf
|
gptkb:person
|
|
gptkbp:almaMater
|
gptkb:Johns_Hopkins_University
gptkb:Johns_Hopkins_School_of_Medicine
|
|
gptkbp:awardReceived
|
gptkb:E._Donnall_Thomas_Prize
gptkb:American_Society_of_Hematology_Scholar_Award
gptkb:Burroughs_Wellcome_Clinical_Scientist_Award_in_Translational_Research
|
|
gptkbp:employer
|
gptkb:Memorial_Sloan_Kettering_Cancer_Center
|
|
gptkbp:fieldOfWork
|
immunotherapy
leukemia research
antibody therapeutics
targeted alpha-particle therapy
|
|
gptkbp:founded
|
gptkb:TCR2_Therapeutics
gptkb:Cellectar_Biosciences
gptkb:Elucida_Oncology
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
David Scheinberg
|
|
gptkbp:member
|
gptkb:American_Society_for_Clinical_Investigation
gptkb:Association_of_American_Physicians
|
|
gptkbp:nationality
|
gptkb:American
|
|
gptkbp:notableStudent
|
gptkb:Siddhartha_Mukherjee
|
|
gptkbp:occupation
|
gptkb:cancer
gptkb:physician
gptkb:scientist
gptkb:immunologist
|
|
gptkbp:position
|
Chair, Experimental Therapeutics Center
Chair, Molecular Pharmacology Program
|
|
gptkbp:researchInterest
|
alpha-particle radioimmunotherapy
development of targeted therapies for cancer
monoclonal antibody development
|
|
gptkbp:bfsParent
|
gptkb:MSKCC
|
|
gptkbp:bfsLayer
|
7
|